Closure of Interatrial Septal Communications: Adverse Events and Lessons Learned

Philipp Wagdi1

  • 1HerzZentrum Hirslanden, Witellikerstrasse 36, 8008 Zurich, Switzerland.

Cardiology Research
|March 29, 2017
PubMed

Insights

A new classification for adverse events (AE) in percutaneous closure of interatrial septal communications (IASC) is proposed. This standardized approach aids in comparing IASC safety and identifying preventable complications.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Medical Device Technology

Background:

  • Percutaneous closure of interatrial septal communications (IASC) is a common procedure.
  • Standardized reporting and classification of adverse events (AE) are lacking for IASC.
  • Previous studies have not focused on AE and their prevention strategies.

Purpose of the Study:

  • To propose a standardized classification for AE in IASC.
  • To evaluate the incidence of major AE using a novel classification system.
  • To identify potential strategies for AE avoidance in IASC.

Main Methods:

  • Retrospective review of 112 consecutive IASC cases performed by a single operator.
  • AE classification adapted from percutaneous coronary intervention (PCI) standards.
  • Detailed review of each AE and potential avoidance measures.

Main Results:

  • Major AE occurred in 2.7% of patients under the proposed classification.
  • AE included cardiac tamponade, device embolization requiring retrieval, and arteriovenous fistula requiring surgical treatment.
  • Two of three major AE might have been preventable with improved patient and device selection.

Conclusions:

  • The proposed AE classification offers a unified and comparable method for IASC procedures.
  • Standardized AE reporting is crucial for improving IASC safety.
  • Careful patient and material selection can potentially reduce major AE in IASC.
Abstract

Related Concept Videos

Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
414
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
556
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
390
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
986
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
331
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
469